CURIS, INC. (CRIS) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2025-12-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2025-12-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2025-12-31..
Borrowing debt
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 19.97M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $19.97M | (m) |
| 2025-09-30 | (m) | (m) | $6.95M | (m) | (m) | (m) | $27.64M | (m) |
| 2025-06-30 | (m) | (m) | $7.35M | (m) | (m) | (m) | $29.23M | (m) |
| 2025-03-31 | (m) | (m) | $7.23M | (m) | (m) | (m) | $39.33M | (m) |
| 2024-12-31 | (m) | (m) | $7.56M | (m) | (m) | $20.00M | $41.27M | (m) |
| 2023-12-31 | (m) | (m) | $8.50M | (m) | (m) | $56.33M | $77.28M | (m) |
| 2021-12-31 | (m) | (m) | $0.00 | (m) | (m) | $115.88M | $162.30M | (m) |
| 2021-09-30 | (m) | (m) | $0.00 | $0.00 | (m) | (m) | $172.09M | (m) |
| 2021-06-30 | (m) | (m) | $0.00 | $0.00 | (m) | (m) | $181.19M | (m) |
| 2021-03-31 | (m) | (m) | $891.00K | $0.00 | (m) | (m) | $190.59M | (m) |
| 2020-12-31 | (m) | (m) | $557.00K | (m) | (m) | $168.49M | $204.36M | (m) |
| 2020-09-30 | (m) | (m) | $222.00K | $668.00K | (m) | $23.55M | $45.71M | (m) |
| 2020-06-30 | (m) | (m) | $445.00K | $445.00K | (m) | $23.77M | $44.95M | (m) |
| 2019-12-31 | (m) | (m) | $0.00 | $0.00 | (m) | $20.54M | $35.11M | (m) |
| 2019-09-30 | (m) | (m) | $0.00 | $0.00 | (m) | $28.01M | $42.24M | (m) |
| 2019-06-30 | (m) | (m) | $0.00 | $0.00 | (m) | $35.32M | $48.24M | (m) |
| 2019-03-31 | (m) | (m) | $0.00 | $0.00 | (m) | $42.80M | $55.45M | (m) |
| 2018-12-31 | (m) | (m) | $6.88M | $28.60M | (m) | $24.27M | $37.37M | (m) |
| 2018-09-30 | (m) | (m) | $6.92M | $30.22M | (m) | $30.83M | $44.27M | (m) |
| 2018-06-30 | (m) | (m) | $6.96M | $31.53M | (m) | $40.42M | $53.19M | (m) |
| 2018-03-31 | (m) | (m) | $7.29M | $32.46M | (m) | $48.45M | $61.38M | (m) |
| 2017-12-31 | (m) | (m) | $5.89M | $35.67M | (m) | $60.23M | $73.80M | (m) |
| 2017-09-30 | (m) | (m) | $5.12M | $37.76M | (m) | $69.23M | $82.37M | (m) |
| 2017-06-30 | (m) | (m) | $3.93M | $39.95M | (m) | $51.04M | $63.80M | (m) |
| 2017-03-31 | (m) | (m) | $3.50M | $41.31M | (m) | $60.80M | $73.76M | (m) |
| 2016-12-31 | (m) | (m) | $4.94M | $14.92M | (m) | $44.48M | $57.75M | (m) |
| 2016-09-30 | (m) | (m) | $5.10M | $15.80M | (m) | $53.35M | $66.19M | (m) |
| 2016-06-30 | (m) | (m) | $5.43M | $16.54M | (m) | $61.67M | $74.10M | (m) |
| 2016-03-31 | (m) | (m) | $5.55M | $17.35M | (m) | $73.12M | $85.32M | (m) |
| 2015-12-31 | (m) | (m) | $4.61M | $19.56M | (m) | $82.19M | $94.97M | (m) |
| 2015-09-30 | (m) | (m) | $4.86M | $20.67M | (m) | $93.47M | $106.11M | (m) |
| 2015-06-30 | (m) | (m) | $4.85M | $21.79M | (m) | $99.19M | $111.58M | (m) |
| 2015-03-31 | (m) | (m) | $5.58M | $21.80M | (m) | $99.96M | $119.31M | (m) |
| 2014-12-31 | (m) | (m) | $5.71M | $22.59M | (m) | $49.75M | $62.61M | (m) |
| 2014-09-30 | (m) | (m) | $5.52M | $23.54M | (m) | $54.60M | $68.21M | (m) |
| 2014-06-30 | (m) | (m) | $5.50M | $24.37M | (m) | $55.77M | $73.90M | (m) |
| 2014-03-31 | (m) | (m) | $3.39M | $26.82M | (m) | $57.76M | $75.36M | (m) |
| 2013-12-31 | (m) | (m) | $2.61M | $27.95M | (m) | $58.18M | $80.59M | (m) |
| 2013-09-30 | (m) | (m) | $1.45M | $29.13M | (m) | $63.22M | $78.55M | (m) |
| 2013-06-30 | (m) | (m) | $1.37M | $29.03M | (m) | $57.13M | $68.20M | (m) |
| 2013-03-31 | (m) | (m) | $314.03K | $29.82M | (m) | $50.50M | $65.09M | (m) |
| 2012-12-31 | (m) | (m) | (m) | $29.84M | (m) | $55.54M | $69.77M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |